About Auxilium Pharmaceuticals
Auxilium Pharmaceuticals is a company based in Philadelphia (United States) founded in 1999 was acquired by Endo International in October 2014. Auxilium Pharmaceuticals has raised $43 million across 1 funding round from investors including Credit Suisse, Endo International and Schroders. Auxilium Pharmaceuticals has completed 1 acquisition, including Actient Pharma. Auxilium Pharmaceuticals operates in a competitive market with competitors including Agile Therapeutics, Xanodyne Pharmaceuticals, Microchips Biotech, Marius Pharmaceuticals and Asarina Pharma, among others.
- Headquarter Philadelphia, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$43 M (USD)
in 1 rounds
-
Latest Funding Round
$43 M (USD), Series D
Nov 07, 2003
-
Investors
Credit Suisse
& 6 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Endo International
(Oct 09, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has successfully raised a total of $43M through 1 strategic funding round. The most recent funding activity was a Series D round of $43 million completed in November 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Endo International and Schroders.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Auxilium Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Auxilium Pharmaceuticals
Auxilium Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Actient Pharma.
Investment portfolio details for Auxilium Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Banned-substance-free sports nutrition supplements are manufactured for athletes and bodybuilders.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Auxilium Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Auxilium Pharmaceuticals
Detailed financials for Auxilium Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Auxilium Pharmaceuticals Comparisons
Peer comparison for Auxilium Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Auxilium Pharmaceuticals
Auxilium Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agile Therapeutics, Xanodyne Pharmaceuticals, Microchips Biotech, Marius Pharmaceuticals and Asarina Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for women's healthcare are developed and offered.
|
|
| Locked | Locked | Locked |
Developer of drugs for women's health and pain management
|
|
| Locked | Locked | Locked |
Microchip implants for wireless drug delivery are developed.
|
|
| Locked | Locked | Locked |
A proprietary oral testosterone replacement therapy platform is developed.
|
|
| Locked | Locked | Locked |
Pharmaceuticals for PMDD, migraine, and Tourette syndrome are developed.
|
Detailed competitors of Auxilium Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Auxilium Pharmaceuticals
Complete news archive for Auxilium Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Auxilium Pharmaceuticals
Auxilium Pharmaceuticals was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Auxilium Pharmaceuticals is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Auxilium Pharmaceuticals is a funded company, having raised a total of $43M across 1 funding round to date.
Auxilium Pharmaceuticals was founded in 1999 and is based in Philadelphia, United States. Therapeutics and drug-device combinations are developed by the company for urology and sexual health, including treatments for hypogonadism (Testim), testosterone replacement (Testopel, Striant), and erectile dysfunction (Edex, Osbon ErecAid, Stendra). Additional development efforts have been directed toward therapies for respiratory diseases and rare disorders within the pharmaceutical sector.
Auxilium Pharmaceuticals's top competitors include Agile Therapeutics, Marius Pharmaceuticals and Peptonic Medical.
Auxilium Pharmaceuticals has made 1 acquisition, including Actient Pharma.
Auxilium Pharmaceuticals has 7 investors. Key investors include Credit Suisse, Endo International, Schroders, Orbimed, and BB Biotech Ventures.